Artículos de revistas
Hyperinsulinemia Caused By Dexamethasone Treatment Is Associated With Reduced Insulin Clearance And Lower Hepatic Activity Of Insulin-degrading Enzyme.
Registro en:
The Journal Of Steroid Biochemistry And Molecular Biology. v. 155, n. Pt A, p. 1-8, 2016-Jan.
1879-1220
10.1016/j.jsbmb.2015.09.020
26386462
Autor
Protzek, André Otávio Peres
Rezende, Luiz Fernando
Costa-Júnior, José Maria
Ferreira, Sandra Mara
Cappelli, Ana Paula Gameiro
Paula, Flávia Maria Moura de
Souza, Jane Cristina de
Kurauti, Mirian Ayumi
Carneiro, Everardo Magalhães
Rafacho, Alex
Boschero, Antonio Carlos
Institución
Resumen
Glucocorticoid treatment induces insulin resistance (IR), which is counteracted by a compensatory hyperinsulinemia, due to increased pancreatic β-cell function. There is evidence for also reduced hepatic insulin clearance, but whether this correlates with altered activity of insulin-degrading enzyme (IDE) in the liver, is not fully understood. Here, we investigated whether hyperinsulinemia, in glucocorticoid-treated rodents, is associated with any alteration in the insulin clearance and activity of the IDE in the liver. Adult male Swiss mice and Wistar rats were treated with the synthetic glucocorticoid dexamethasone intraperitoneally [1mg/kg body weight (b.w.)] for 5 consecutive days. Glucocorticoid treatment induced IR and hyperinsulinemia in both species, but was more impactful in rats that also displayed glucose intolerance and hyperglycemia. Insulin clearance was reduced in glucocorticoid-treated rats and mice, as judged by the reduction of insulin decay rate and increased insulin area-under-the-curve (47% and 87%, respectively). These results were associated with reduced activity (35%) of hepatic IDE in rats and a tendency to reduction (p=0.068) in mice, without alteration in hepatic IDE mRNA content, in both species. In conclusion, the reduced insulin clearance in glucocorticoid-treated rodents was due to the reduction of hepatic IDE activity, at least in rats, which may contributes to the compensatory hyperinsulinemia. These findings corroborate the idea that short-term and/or partial inhibition of IDE activity in the liver could be beneficial for the glycemic control. 155 1-8
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Glucose-induced Insulin Secretion Is Impaired And Insulin-induced Phosphorylation Of The Insulin Receptor And Insulin Receptor Substrate-1 Are Increased In Protein-deficient Rats
Reis M.A.B.; Carneiro E.M.; Mello M.A.R.; Boschero A.C.; Saad M.J.A.; Velloso L.A. -
Glucose-induced insulin secretion is impaired and insulin-induced phosphorylation of the insulin receptor and insulin receptor substrate-1 are increased in protein-deficient rats
Reis, Marise A.B.; Carneiro, Everardo M.; Mello, Maria A.R.; Boschero, A. Carlos; Saad, Mario J. A.; Velloso, Licio A. -
Glucose-induced Insulin Secretion Is Impaired And Insulin-induced Phosphorylation Of The Insulin Receptor And Insulin Receptor Substrate-1 Are Increased In Protein-deficient Rats.
Reis, M A; Carneiro, E M; Mello, M A; Boschero, A C; Saad, M J; Velloso, L A